Jonas Marschall - Infectious Diseases

Author Information

Jonas Marschall is an esteemed researcher affiliated with the Division of Infectious Diseases at the Department of Medicine, Washington University School of Medicine, located in St. Louis, Missouri, USA. His affiliation with such a prestigious institution highlights his significant contributions to the field of infectious diseases, especially in clinical and epidemiological research.

Research Contributions

Jonas Marschall has made substantial contributions to the field of infectious diseases, with particular focus on hospital-acquired infections, viral epidemiology, and the clinical implications of infectious diseases. His recent publications cover a range of topics including serological testing for SARS-CoV-2 antibodies, strategies for preventing central line-associated bloodstream infections, and models for estimating the prevalence of infectious outbreaks in healthcare settings. His work is instrumental in advancing our understanding of infection control and improving clinical practices in healthcare environments.

Aliases

Jonas Marschall is also known by several aliases in academic publications, including J Marschall and J. Marschall. These variations may appear in different research articles or databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	6720
h-index	36
Total Paper Count	193

Publications:

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study.

DOI: 10.1111/all.15206

Year: 2022

Meticillin-resistant Staphylococcus aureus Contact Screening Strategy in a Low Prevalence Setting; a Nested Case-Control Study

DOI: 10.1016/j.infpip.2022.100211

Year: 2022

Agrobacterium species bacteraemia, Switzerland, 2008 to 2019: a molecular epidemiological study

DOI: 10.1186/s13756-022-01086-y

Year: 2022

Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections

DOI: 10.1186/s13756-021-01038-y

Year: 2022

Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.

DOI: 10.1017/ice.2022.87

Year: 2022

A Bayesian spatial-temporal model for prevalence estimation of a VRE outbreak in a tertiary care hospital.

DOI: 10.1016/j.jhin.2021.12.024

Year: 2022

Surveillance quality correlates with surgical site infection rates in knee and hip arthroplasty and colorectal surgeries: A call to action to adjust reporting of SSI rates

DOI: 10.1017/ice.2021.14

Year: 2021

Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)

DOI: 10.1101/2021.09.14.21263153

Year: 2021

795. A Bayesian Spatial-temporal Modelling Approach for Prevalence Estimation of a VRE Outbreak in a Tertiary Care Hospital

DOI: 10.1093/ofid/ofab466.991

Year: 2021

Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort study.

DOI: 10.4414/smw.2021.20547

Year: 2021

How Can Yellow Fever Be Prevented?

What is Yellow Fever Virus?

What is the Future of Vaccinations?

What is Vertical Transmission?

What Role Do Antimicrobial Resistance Play?

How Can Food and Water Contamination be Prevented?

What is the Impact of Vaccinations on Public Health?

What are the benefits of Dengvaxia?

What are the main challenges in diagnosing Infectious Diseases?

How Can We Prevent the Spread of Aedes Albopictus?

Partnered Content Networks

Relevant Topics